z-logo
open-access-imgOpen Access
The use of Ivermectin for the treatment of COVID-19: Panacea or enigma?
Author(s) -
Helen Onyeaka,
Phemelo Tamasiga,
Joy Onyinyechi Chionuma,
Oreneile Anikie Mokgwathi,
Olivier Uwishema
Publication year - 2022
Publication title -
clinical epidemiology and global health
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.361
H-Index - 13
eISSN - 2452-0918
pISSN - 2213-3984
DOI - 10.1016/j.cegh.2022.101074
Subject(s) - ivermectin , panacea (medicine) , pandemic , medicine , intensive care medicine , covid-19 , social distance , population , isolation (microbiology) , transmission (telecommunications) , outbreak , environmental health , virology , veterinary medicine , alternative medicine , disease , biology , bioinformatics , infectious disease (medical specialty) , pathology , electrical engineering , engineering

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here
Accelerating Research

Address

John Eccles House
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom